BusinessMember
J&J consumer health subsidiary goes public, shares jump 22 percent
Kenvue, the consumer health subsidiary of Johnson & Johnson (J&J), has gone public after announcing plans of its “upsized” initial public offering (IPO) on the New York Stock Exchange (NYSE) last week. The firm’s common stock aimed to initially come in at 22 dollars per share under the symbol KVUE, however closed at 26.90 dollars after opening...
loading...